Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Polymyositis”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Looking for participantsNCT07089121
What this trial is testing

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

Who this might be right for
Childhood-onset Systemic Lupus ErythematousANCA-Associated Vasculitis (AAV)Juvenile Myasthenia Gravis+1 more
Cartesian Therapeutics 50
Testing effectiveness (Phase 2)Study completedNCT05192200
What this trial is testing

An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

Who this might be right for
Dermatomyositis
Pfizer 24
Not applicableStudy completedNCT01734369
What this trial is testing

Environmental Risk Factors for Myositis in Military Personnel

Who this might be right for
DermatomyositisAdult PolymyositisInclusion Body Myositis+1 more
National Institute of Environmental Health Sciences (NIEHS) 37
Testing effectiveness (Phase 2)WithdrawnNCT07012057
What this trial is testing

Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis

Who this might be right for
MyositisDermatomyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Large-scale testing (Phase 3)Looking for participantsNCT06455449
What this trial is testing

Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Who this might be right for
Polymyositis, Dermatomyositis
AstraZeneca 240
Not applicableLooking for participantsNCT01276470
What this trial is testing

Environmental Risk Factors for the Anti-synthetase Syndrome

Who this might be right for
MyositisDermatomyositisPolymyositis+2 more
National Institute of Environmental Health Sciences (NIEHS) 580
Post-approval studies (Phase 4)UnknownNCT04966884
What this trial is testing

The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients

Who this might be right for
Dermatomyositis, Adult Type
First Affiliated Hospital Xi'an Jiaotong University 20
Early research (Phase 1)Study completedNCT00533091
What this trial is testing

Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis

Who this might be right for
DERMATOMYOSITIS OR POLYMYOSITIS
MedImmune LLC 51
Not applicableUnknownNCT01482494
What this trial is testing

Detection of Pompe Disease in Adult Patients With Myopathies of Uncertain Origin or With Asymptomatic Hyper-CK-emia

Who this might be right for
Pompe Disease
Jordi Perez Lopez 50
Early research (Phase 1)Looking for participantsNCT07085104
What this trial is testing

Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis
Allogene Therapeutics 54
Not applicableLooking for participantsNCT07377058
What this trial is testing

RCT of Tocilizumab for Anti-MDA5+DM

Who this might be right for
Dermatomyositis
Peking Union Medical College Hospital 110
Testing effectiveness (Phase 2)Study completedNCT02612857
What this trial is testing

Trial of IMO-8400 in Adult Patients With Dermatomyositis

Who this might be right for
Dermatomyositis
Idera Pharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00106184
What this trial is testing

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

Who this might be right for
MyositisDermatomyositisPolymyositis+1 more
University of Pittsburgh 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06284954
What this trial is testing

Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

Who this might be right for
DermatomyositisMyositis
argenx 3
Early research (Phase 1)Looking for participantsNCT06916806
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesRheumatoid Arthritis
AstraZeneca 72
Testing effectiveness (Phase 2)Study completedNCT06433999
What this trial is testing

A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis

Who this might be right for
DermatomyositisDermatomyositis, Adult Type
Priovant Therapeutics, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT05669014
What this trial is testing

Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)

Who this might be right for
Idiopathic Inflammatory Myositis
Amgen 12
Testing effectiveness (Phase 2)Study completedNCT01572844
What this trial is testing

Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis

Who this might be right for
Calcinosis
Alison Ehrlich 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05695950
What this trial is testing

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

Who this might be right for
Dermatomyositis
Galapagos NV 40
Large-scale testing (Phase 3)Ended earlyNCT04044690
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)

Who this might be right for
Dermatomyositis
CSL Behring 134
Load More Results